Comparison of different prophylactic regimens for Thai children with moderate and severe haemophilia A

被引:1
|
作者
Na Songkla, Pokpong [1 ]
Seksarn, Panya [1 ]
Sosothikul, Darintr [1 ]
机构
[1] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Div Hematol & Oncol, Dept Pediat,Fac Med, Bangkok, Thailand
关键词
D O I
10.1111/hae.13992
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E211 / E213
页数:3
相关论文
共 50 条
  • [31] VERITAS-Pro: a new measure of adherence to prophylactic regimens in haemophilia
    Duncan, N.
    Kronenberger, W.
    Roberson, C.
    Shapiro, A.
    HAEMOPHILIA, 2010, 16 (02) : 247 - 255
  • [32] Screening of haemophilia carriers in moderate and severe haemophilia A and B: Prevalence and determinants
    Bernard, W.
    Lambert, C.
    Henrard, S.
    Hermans, C.
    HAEMOPHILIA, 2018, 24 (03) : E142 - E144
  • [33] Severe and moderate haemophilia A and B in US females
    Di Michele, D. M.
    Gibb, C.
    Lefkowitz, J. M.
    Ni, Q.
    Gerber, L. M.
    Ganguly, A.
    HAEMOPHILIA, 2014, 20 (02) : E136 - E143
  • [34] Moderate and severe haemophilia in Spain: An epidemiological update
    Aznar, J. A.
    Altisent, C.
    Alvarez-Roman, M. T.
    Bonanad, S.
    Mingot-Castellano, M. E.
    Lopez, M. F.
    HAEMOPHILIA, 2018, 24 (03) : E136 - E139
  • [35] Controversies regarding the prophylactic management of adults with severe haemophilia A
    Valentino, L. A.
    Blatt, Philip M.
    Brettler, Doreen B.
    Kessler, Craig
    Key, Nigel S.
    Ma, Alice
    Manco-Johnson, Marilyn
    Neff, Anne T.
    Penner, John A.
    Powell, Jerry S.
    Recht, Michael
    Tarantino, Michael
    Walsh, Christopher
    HAEMOPHILIA, 2009, 15 : 5 - 22
  • [36] PROSPECTIVE RANDOMIZED COMPARISON OF TOXICITY OF 2 PROPHYLACTIC REGIMENS OF COTRIMOXAZOLE IN LEUKEMIC CHILDREN
    ARICO, M
    MOLINARI, E
    BACCHELLA, L
    DEAMICI, M
    RAITERI, E
    BURGIO, GR
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1992, 9 (01) : 35 - 40
  • [37] Prophylactic treatment for severe haemophilia: comparison of an intermediate-dose to a high-dose regimen
    Fischer, K
    Astermark, J
    Van der Bom, JG
    Ljung, R
    Berntorp, E
    Grobbee, DE
    Van den Berg, HM
    HAEMOPHILIA, 2002, 8 (06) : 753 - 760
  • [38] The societal burden of haemophilia A. II - The cost of moderate and severe haemophilia A in Australia
    Brown, Laurie J.
    La, Hai A.
    Li, Jinjing
    Brunner, Matthias
    Snoke, Martin
    Kerr, Annette M.
    HAEMOPHILIA, 2020, 26 : 11 - 20
  • [39] Comparison of spontaneous bleeding incidents despite use of prophylactic factor treatments in the era of emicizumab use over 12 months for patients with moderate or severe haemophilia A in an adult haemophilia treatment centre South Australia
    Lin, Yu-Hsuan
    HAEMOPHILIA, 2024, 30 : 137 - 138
  • [40] Comparison of two different regimens of intravenous methylprednisolone for patients with moderate to severe and active Graves' ophthalmopathy: a prospective, randomized controlled trial
    He, Yebing
    Mu, Ketao
    Liu, Rong
    Zhang, Jing
    Xiang, Nan
    ENDOCRINE JOURNAL, 2017, 64 (02) : 141 - 149